Earlier in 2014, the U.S. Food and Drug Administration sent a warning letter to American Medical Systems (AMS) following a growing number of lawsuits against the company due to faulty transvaginal mesh devices (TVM), and a statement from parent company Endo International PLC announced that AMS will move forward with the 522 postmarket surveillance study for the Elevate product.
New Non-Profit Hopes to Raise Transvaginal Mesh Awareness
Transvaginal mesh lawsuits continue to be filed in courts around the U.S. as women who were treated with the device after suffering pelvic organ prolapse (POP) or stress urinary incontinence, but they suffered serious complications that lead to the need to surgical removal of the mesh.
Three of Four Major TVM Manufacturers Refuse to Settle
Women around the country are continuing to file transvaginal mesh (TVM) lawsuits against manufacturers of the devices that are used to treat pelvic organ prolapse (POP) and stress urinary incontinence because the mesh can lead to serious complications and require surgical removal.
Pfizer Fails to Get Depo Testosterone Lawsuits Excluded from MDL
Men around the country have filed low testosterone lawsuits against manufacturers of treatments for this condition after suffering heart attacks, strokes and other cardiovascular events.
Multidistrict Litigation for Low Testosterone Lawsuits Moves Forward
Men around the country have been filing lawsuits against the manufacturers of low testosterone treatments after suffering strokes, heart attacks and other life-threatening cardiac events.
New Low Testosterone Blood Clot Drug Warning Labels Announced by FDA
The U.S. Food and Drug Administration released a statement Thursday, January 19, 2014, telling low testosterone treatment manufacturers that a warning needs to be added to the drug label regarding users’ increased risk of blood clots in veins.
Man Files Wrongful Death Lawsuit Against Low Testosterone Drug Maker
A low testosterone lawsuit was recently filed in the U.S. District Court for the Northern District of Illinois stating the manufacturers of low-T treatments AbbVie, Abbott Laboratories, Lilly USA Inc., and Eli Lilly and Company took part in aggressive marketing of the drugs that mislead men about the treatments’ safety and efficacy.
Almost 100 Federal Cases Pending Over Low Testosterone Supplements
Men around the country have been filing low testosterone lawsuits against drug manufacturers after suffering strokes, heart attacks and other cardiovascular events as a result of taking these medications.
TVM Manufacturer American Medical Systems Warned by FDA
American Medical Systems, which manufactures transvaginal mesh devices, received a warning letter from the U.S. Food and Drug Administration (FDA) regarding issues the organization found at a facility run by the company. These included risk analysis and process validation procedures.
Texas Man Files Complaint Against Low Testosterone Therapy
A man from Texas has joined countless others in filing a product liability personal injury lawsuit against the manufacturers of the low testosterone treatment AndroGel.